Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Christopher P. Evans, MD

Advertisement

Articles by Christopher P. Evans, MD

The argument for surgical management of high-risk prostate cancer

BySigfred Ian R. Alpajaro, MD,Christopher P. Evans, MD
August 16th 2018

Radical prostatectomy can provide superior survival compared with radiation therapy, especially in young and healthy men.

Advertisement

Latest Updated Articles

  • The argument for surgical management of high-risk prostate cancer
    The argument for surgical management of high-risk prostate cancer

    Published: August 16th 2018 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD

2

FDA approves sildenafil oral film for men with erectile dysfunction

3

Pearls & Perspectives: Modern Semen Testing and Male Fertility Care, with Thomas Masterson, MD

4

Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC

5

URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us